CVS

CVS Health Corporation [CVS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

CVS Stock Summary

Top 10 Correlated ETFs

CVS


Top 10 Correlated Stocks

CVS


In the News

03:20 22 Feb 2024 CVS

3 Cash Cows to Boost Your Confidence During the February Chill

What are cash cow stocks? If “Jeopardy!

11:06 22 Feb 2024 CVS

Here's Why You Should Retain CVS Health (CVS) Stock for Now

Investors are optimistic about CVS Health (CVS) on its strong segmental performance and impressive restructuring plan.

08:50 22 Feb 2024 CVS

CVS Health (CVS) Gains From Digital Adoption Amid Competition

CVS Health (CVS) has been removing barriers to digital adoption and making it easier for customers to access services such as pharmacy refills and advanced scheduling for immunizations online.

10:00 22 Feb 2024 CVS

Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know

CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

05:33 22 Feb 2024 CVS

Yields Up To 5.8%, Top 3 Dividend Stocks To Buy In February

Yields Up To 5.8%, Top 3 Dividend Stocks To Buy In February

08:00 22 Feb 2024 CVS

CVS Sticking With Clinic Expansion Strategy Despite Walgreens Woes

CVS Health chief executive officer Karen Lynch said the healthcare giant is sticking with its expansion strategy for Oak Street Health to open 50 to 60 clinics for seniors next year.

05:26 22 Feb 2024 CVS

CVS has natural hedges built in the business due to healthcare, managed care, and pharmacy: Analyst

Despite reporting better-than-expected fourth-quarter earnings results, CVS Health (CVS) had to cut its full-year outlook due to medical cost pressures. Piper Sandler Healthcare Analyst Jessica Tassan tells Yahoo Finance Live that CVS's “diversified business model” could help mitigate some of the impacts of Medicare Advantage costs.

03:05 22 Feb 2024 CVS

The 3 Most Undervalued Stocks With Strong Fundamentals to Buy in February 2024

The broader indices like the S&P 500 are turning lower and the loom of a recession nears, the Fed attempts its soft landing. Therefore, it's more important than ever for investors to concentrate their holdings on undervalued stocks with strong fundamentals.

02:25 22 Feb 2024 CVS

CVS Beats Estimates, but Cuts Full-Year Profit Outlook on Higher Medical Costs

CVS Healthcare (CVS) shares gained ground on Wednesday after the company reported better-than-expected earnings but lowered its 2024 guidance due to an increase in insurance payouts.

01:53 22 Feb 2024 CVS

CVS Enhances Omnichannel Services to Offer Customers More Connected Healthcare Experience

CVS Health announced profitable fourth-quarter (Q4) and full-year earnings on Wednesday (Feb. 7), crediting initiatives to improve primary care and expand omnichannel health services. These efforts aim to provide consumers with accessible care options, whether in-person, virtually or at home, the company told investors on a call.

CVS Financial details

Company Rating
Strong Buy
Market Cap
97.03B
Income
8.34B
Revenue
357.78B
Book val./share
59.36
Cash/share
6.36
Dividend
2.48
Dividend %
3.21%
Employees
219K
Optionable
Yes
Shortable
Yes
Earnings
01 May 2024
P/E
11.91
Forward P/E
9.21
PEG
1.13
P/S
0.27
P/B
1.3
P/C
12.1
P/FCF
9.34
Quick Ratio
0.55
Current Ratio
0.86
Debt / Equity
0.98
LT Debt / Equity
0.97
-
-
EPS (TTM)
6.49
EPS next Y
8.36
EPS next Q
2.25
EPS this Y
105.38%
EPS next Y
28.86%
EPS next 5Y
28.86%
EPS last 5Y
4.94%
Revenue last 5Y
6.86%
Revenue Q/Q
4.51%
EPS Q/Q
-9.66%
-
-
-
-
SMA20
4.05%
SMA50
6.94%
SMA100
8.45%
Inst Own
64.72%
Inst Trans
0.85%
ROA
3%
ROE
11%
ROC
0.08%
Gross Margin
-22%
Oper. Margin
4%
Profit Margin
2%
Payout
38%
Shs Outstand
1.26B
Shs Float
1.26B
-
-
-
-
Target Price
112.63
52W Range
64.41-88.75
52W High
-12.55%
52W Low
+20.25%
RSI
57
Rel Volume
0.19
Avg Volume
10.93M
Volume
2.12M
Perf Week
0.48%
Perf Month
-2.88%
Perf Quarter
18.09%
Perf Half Y
14.73%
-
-
-
-
Beta
0.49
-
-
Volatility
0.34%, 1.78%
Prev Close
-0.25%
Price
76.96
Change
0.84%

CVS Financial Performance

Yearly Fundamentals Overview

Last date of statement is

Metric History

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
6466.4769.3169.7572.84
Net income per share
1.761.661.481.761.59
Operating cash flow per share
-1.495.84.62.11-2.05
Free cash flow per share
-2.025.034.141.69-2.75
Cash per share
1213.8113.1612.586.36
Book value per share
54.2155.6456.6857.7659.36
Tangible book value per share
-24.11-30.28-37.71-36.03-34.06
Share holders equity per share
54.2155.6456.6857.7659.36
Interest debt per share
54.4260.0764.5562.7758.67
Market cap
122.08B95.34B88.69B89.86B101.7B
Enterprise value
179.87B157.2B157.02B156.91B168.38B
P/E ratio
13.2611.1611.669.9412.43
Price to sales ratio
1.461.12111.08
POCF ratio
-62.5412.8215.0133.08-38.58
PFCF ratio
-46.2414.7716.6841.39-28.67
P/B Ratio
1.721.341.221.211.33
PTB ratio
1.721.341.221.211.33
EV to sales
2.151.841.771.751.79
Enterprise value over EBITDA
47.6832.6332.3442.5249.92
EV to operating cash flow
-92.1421.1326.5857.77-63.88
EV to free cash flow
-68.1324.3629.5372.28-47.47
Earnings yield
0.020.020.020.030.02
Free cash flow yield
-0.020.070.060.02-0.03
Debt to equity
11.071.131.080.98
Debt to assets
0.310.320.330.320.3
Net debt to EBITDA
15.3212.8414.0718.1719.77
Current ratio
0.940.920.860.860.86
Interest coverage
4.935.854.715.324.89
Income quality
-0.853.473.091.2-1.29
Dividend Yield
0.010.010.010.010.01
Payout ratio
0.310.360.420.340.38
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
0.450.460.490.480.48
Capex to operating cash flow
0.35-0.13-0.1-0.20.35
Capex to revenue
-0.01-0.01-0.01-0.01-0.01
Capex to depreciation
-0.66-0.98-0.54-0.48-0.8
Stock based compensation to revenue
00000
Graham number
46.345.6543.4747.7846.06
ROIC
0.010.020.010.020.02
Return on tangible assets
0.020.020.010.020.02
Graham Net
-84.91-93.26-100.84-98.63-100.51
Working capital
-4.05B-6.35B-11.45B-11.41B-11.33B
Tangible asset value
-31.59B-38.85B-48.38B-46.38B-43.87B
Net current asset value
-91.28B-99.04B-109.31B-106.65B-105.23B
Invested capital
11.071.131.080.98
Average receivables
26.92B27.8B28.94B31.24B34.08B
Average payables
14.38B13.68B12.95B14.12B14.89B
Average inventory
18.57B18.68B17.78B17.62B17.99B
Days sales outstanding
29.2829.929.933.0133.8
Days payables outstanding
19.0715.6815.979.519.07
Days of inventory on hand
24.5322.8620.6611.4810.97
Receivables turnover
3.073.013.012.732.66
Payables turnover
4.725.745.639.469.93
Inventory turnover
3.673.944.367.848.2
ROE
0.030.030.030.030.03
Capex per share
-0.53-0.77-0.46-0.42-0.71

CVS Frequently Asked Questions

What is CVS Health Corporation stock symbol ?

CVS Health Corporation is a US stock , located in Woonsocket of Ri and trading under the symbol CVS

Is CVS Health Corporation buy or a sell ?

31 stock analysts have 31 predictions with a medium analyst target price of $113.19. The lowest prediction is $80 and the highest is $127

What is CVS stock prediction ?

With a median analyst target price of $100, 1 stock analysts have made 1 forecasts in last 90 days. $100 is the lowest and $100 is the greatest projection.

What is CVS Health Corporation stock quote today ?

CVS Health Corporation stock price is $76.96 today.

Is CVS Health Corporation stock public?

Yes, CVS Health Corporation is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap